NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A therapeutics company developing targeted solutions for dermatology and oncology.
United Kingdom
INC
INCYTE CORP Logo
A biopharmaceutical company developing proprietary therapeutics for unmet medical needs.
United States of America
INCY
Indivior PLC Logo
Pharmaceutical company developing medicines for substance use and mental disorders.
United Kingdom
INDV
Infant Bacterial Therapeutics Logo
Develops microbiome drugs to prevent or treat rare diseases in premature infants.
Sweden
IBT
Inhibikase Therapeutics, Inc. Logo
Develops kinase inhibitors for neurodegenerative and rare cardiopulmonary conditions.
United States of America
IKT
Inhibrx Biosciences, Inc. Logo
A clinical-stage biopharma company developing biologic therapeutics for oncology.
United States of America
INBX
InMed Pharmaceuticals Inc. Logo
Develops cannabinoid-based drugs and manufactures rare cannabinoids for B2B markets.
United States of America
INM
Inmune Bio, Inc. Logo
A clinical-stage biotech reprogramming the immune system to fight cancer and neurodegeneration.
United States of America
INMB
Innate Pharma Logo
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
France
IPH
INNOGENE Co., Ltd. Logo
Develops and distributes anti-aging products for skin regeneration and hair health.
South Korea
344860

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.